Abstract |
Alzheimer's disease (AD) could be considered a multifactorial neurodegenerative disorder characterized by the accumulation of the β- amyloid- peptide (Aβ) within the brain leading to cognitive deficits, oxidative stress, and neuroinflammation. The present work was carried out to investigate the neuroprotective effect of (-)-cis- carveol (1% and 3%, for 21 days) against the β- amyloid- peptide 1-42- (Aβ1-42-) induced AD. Twenty-five rats were divided into five groups (n = 5/group): the first group-control ( sham-operated); the second group-Aβ1-42 (1 mM) that received donepezil treatment (5 mg/kg, as the positive reference drug in the Y-maze and the radial arm maze tests); the third group-Aβ1-42 (1 mM); the fourth and fifth groups-Aβ1-42 (1 mM) that received (-)-cis- carveol treatment groups (1% and 3%). The results of this study demonstrated that (-)-cis- carveol improved Aβ1-42-induced memory deficits examined by using Y-maze and radial arm maze in vivo tests. Also, the biochemical analyses of the hippocampus homogenates showed that (-)-cis- carveol reduced hippocampal oxidative stress caused by Aβ1-42. Our results suggested that the use of (-)-cis- carveol may be suitable for decreasing AD-related symptoms.
|
Authors | Lucian Hritcu, Razvan Stefan Boiangiu, Mayara Castro de Morais, Damião Pergentino de Sousa |
Journal | BioMed research international
(Biomed Res Int)
Vol. 2020
Pg. 8082560
( 2020)
ISSN: 2314-6141 [Electronic] United States |
PMID | 32382574
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Lucian Hritcu et al. |
Chemical References |
- Amyloid beta-Peptides
- Cyclohexane Monoterpenes
- Neuroprotective Agents
- Peptide Fragments
- amyloid beta-protein (1-42)
- carveol
|
Topics |
- Alzheimer Disease
(drug therapy, metabolism, pathology, physiopathology)
- Amyloid beta-Peptides
(metabolism)
- Animals
- Cyclohexane Monoterpenes
(pharmacology)
- Hippocampus
(metabolism, pathology, physiopathology)
- Male
- Memory Disorders
(drug therapy, metabolism, pathology, physiopathology)
- Neuroprotective Agents
(pharmacology)
- Oxidative Stress
(drug effects)
- Peptide Fragments
(metabolism)
- Rats
- Rats, Wistar
|